ArticleFrontiers in cardiovascular medicine2022

Long-term prognostic value of macrophage migration inhibitory factor in ST-segment elevation myocardial infarction patients with metabolic syndrome after percutaneous coronary intervention.

Xiao-Lin Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.